GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistetroside-5

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2230Cleistetroside-5E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2238Cleistetroside-5E. coli impMIC (μM)1610.1021/ml300303g
act2246Cleistetroside-5B. subtilis JH642MIC (μM)810.1021/ml300303g
act2254Cleistetroside-5NCI-H460MIC (μM)15.410.1021/ml300303g
act2366Cleistetroside-5S. aureus ATCC 33591MIC (μg/mL)810.1021/ml300303g
act2369Cleistetroside-5S. aureus 78-13607AMIC (μg/mL)810.1021/ml300303g
act2371Cleistetroside-5Staphylococcus aureus ATCC 29213 (oxacillin-susceptible)MIC (μg/mL)2Phase I10.1021/ml300303g
act2373Cleistetroside-5Staphylococcus aureus ATCC 33591 (oxacillin-resistant)MIC (μg/mL)2Phase I10.1021/ml300303g
act2375Cleistetroside-5Staphylococcus epidermidis clinical isolate 12-1788A (oxacillin-susceptible)MIC (μg/mL)4Phase I10.1021/ml300303g
act2377Cleistetroside-5Staphylococcus haemolyticus clinical isolate 107-1240C (oxacillin-resistant)MIC (μg/mL)4Phase I10.1021/ml300303g
act2379Cleistetroside-5Enterococcus faecalis ATCC 29212 (ampicillin-susceptible, vancomycin-susceptible)MIC (μg/mL)4Phase I10.1021/ml300303g
act2381Cleistetroside-5Enterococcus faecium clinical isolate 24-45A (ampicillin-resistant, vancomycin-resistant)MIC (μg/mL)2Phase I10.1021/ml300303g
act2383Cleistetroside-5Streptococcus pneumoniae ATCC 49619 (penicillin-intermediate)MIC (μg/mL)8Phase I10.1021/ml300303g
act2385Cleistetroside-5Streptococcus pneumoniae clinical isolate 33-50B (penicillin-resistant)MIC (μg/mL)8Phase I10.1021/ml300303g
act2387Cleistetroside-5Corynebacterium jeikium clinical isolate 15-196A (wild-type)MIC (μg/mL)>32Phase I10.1021/ml300303g
act2389Cleistetroside-5Bacillus cereus clinical isolate 24-59A (wild-type)MIC (μg/mL)2Phase I10.1021/ml300303g
act2391Cleistetroside-5Streptococcus pyogenes clinical isolate 91-8747 (erythromycin-resistant)MIC (μg/mL)8Phase I10.1021/ml300303g
act2393Cleistetroside-5Streptococcus mitis clinical isolate 61-2900C (penicillin-resistant)MIC (μg/mL)8Phase I10.1021/ml300303g
act2395Cleistetroside-5Pseudomonas aeruginosa ATCC 27853MIC (μg/mL)>32Phase I10.1021/ml300303g
act2397Cleistetroside-5Escherichia coli ATCC 25922MIC (μg/mL)>32Phase I10.1021/ml300303g
act2399Cleistetroside-5Staphylococcus aureus 4-90A (mupirocin-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2401Cleistetroside-5Staphylococcus aureus 300-12053A (quinupristin/dalfopristin-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2403Cleistetroside-5Staphylococcus aureus 106-12591A (linezolid-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2405Cleistetroside-5Coagulase-negative staphylococci 63-18A (mupirocin-resistant)MIC (μg/mL)2 - 4Phase II10.1021/ml300303g
act2407Cleistetroside-5Coagulase-negative staphylococci 90-10840A (quinupristin/dalfopristin-resistant)MIC (μg/mL)2 - 4Phase II10.1021/ml300303g
act2409Cleistetroside-5Coagulase-negative staphylococci 82-1645A (linezolid-resistant)MIC (μg/mL)2 - 4Phase II10.1021/ml300303g
act2411Cleistetroside-5Enterococcus faecalis 48-22D (vancomycin-resistant,vanA phenotype)MIC (μg/mL)2Phase II10.1021/ml300303g
act2413Cleistetroside-5Enterococcus faecalis 82-876D (vancomycin-resistant, vanB phenotype)MIC (μg/mL)2Phase II10.1021/ml300303g
act2415Cleistetroside-5Enterococcus faecalis 15-534I (linezolid-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2417Cleistetroside-5Enterococcus faecalis 39-11D (high-level gentamicin and streptomycin-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2419Cleistetroside-5Enterococcus faecium 15-206A (vancomycin-resistant, vanA phenotype)MIC (μg/mL)2Phase II10.1021/ml300303g
act2421Cleistetroside-5Enterococcus faecium 103-1232D (vancomycin-resistant, vanB phenotype)MIC (μg/mL)2Phase II10.1021/ml300303g
act2423Cleistetroside-5Enterococcus faecium 11-4103A (linezolid-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2425Cleistetroside-5Enterococcus faecium 65-1208A (quinupristin/dalfopristin-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2427Cleistetroside-5Bacillus spp. 107-1461D (tetracycline-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2429Cleistetroside-5Bacillus spp. 67-1057A (trimethoprim/ sulfamethoxazole-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2431Cleistetroside-5Bacillus spp. 32-2406A (erythromycin-resistant)MIC (μg/mL)2Phase II10.1021/ml300303g
act2433Cleistetroside-5Streptococcus pneumoniae 68-2307B (multidrug-resistant)MIC (μg/mL)4 - 16Phase II10.1021/ml300303g
act2435Cleistetroside-5Streptococcus pneumoniae 4-38B (erythromycin-resistant, clindamycin-resistant)MIC (μg/mL)4 - 16Phase II10.1021/ml300303g
act2437Cleistetroside-5Streptococcus pneumoniae 35-405B (erythromycin-resistant, clindamycin-susceptible)MIC (μg/mL)4 - 16Phase II10.1021/ml300303g
act2439Cleistetroside-5Streptococcus pneumoniae 2-2784A (levofloxacin-resistant)MIC (μg/mL)4 - 16Phase II10.1021/ml300303g
act2441Cleistetroside-5Corynebacterium spp. 105-1513C (doxycycline-resistant)MIC (μg/mL)8Phase II10.1021/ml300303g
act2443Cleistetroside-5Corynebacterium spp. 58-9161A (rifampin-resistant)MIC (μg/mL)8Phase II10.1021/ml300303g
act2445Cleistetroside-5Corynebacterium spp. 61-5454A (high-level streptomycin-resistant)MIC (μg/mL)8Phase II10.1021/ml300303g
act2447Cleistetroside-5β-haemolytic streptococci 91-526D (erythromycin-resistant, clindamycin-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g
act2449Cleistetroside-5β-haemolytic streptococci 109-820D (erythromycin-resistant, clindamycin-susceptible)MIC (μg/mL)4Phase II10.1021/ml300303g
act2451Cleistetroside-5β-haemolytic streptococci 19-756A (levofloxacin-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g
act2453Cleistetroside-5viridans group streptococci 32-2395A (mupirocin-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g
act2455Cleistetroside-5viridans group streptococci 107-6380A (levofloxacin-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g
act2457Cleistetroside-5viridans group streptococci 27-2832A (linezolid-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g
act2459Cleistetroside-5viridans group streptococci 58-1602D (multidrug-resistant)MIC (μg/mL)4Phase II10.1021/ml300303g